Middle East and Africa Anatomic Pathology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and Service (Instruments, Consumables, and Services), Application (Disease Diagnosis, Drug Discovery and Development, and Others) and End user (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others)

Code: TIPRE00026305 | Pages: 138 | Industry: Biotechnology | Date: Dec 2021
Covid

Market Introduction

The anatomic pathology is a significant part of the study and treatment of the diseases. Anatomic pathology is a broad field that includes decedent pathology, surgical pathology, cytopathology, neuropathology, and ophthalmic pathology. The anatomic pathology is usually performed in the medical laboratories of hospitals and diagnostics laboratories.

 


Get more information on this report :



Market Overview and Dynamics

The Middle East and Africa anatomic pathology market is expected to reach US$ 1,117.01 million by 2028 from US$ 840.20 million in 2021; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as increase in prevalence of cancer and other diseases, growing focus on personalized medicines are driving the growth of the Middle East and Africa anatomic pathology market. However, the market is being hampered by lack of skilled professionals and stringency of government regulations.

Personalized medicines are mainly designed by considering individuals’ genetic profiles to guide decisions made with respect to the prevention, diagnosis, and treatment of a disease. They provide an opportunity for medical device and drug manufacturers to develop agents that are targeted to patient groups that do not respond to medications as intended or that do not respond as expected to the traditional healthcare practices. There is much evidence indicating that a substantial portion of the variability in drug response depends on factors that are genetically controlled, e.g., age, nutrition, environmental exposure, and health status. Genomics plays an important role in the emergence of personalized medicines, as having the knowledge of a patient's genetic profile would help doctors in selecting an apt medication. Personalized medicines are useful for improving healthcare by enabling each patient to receive earlier diagnoses, risk assessments, and optimal treatments. The pathologists plays an important role in developing and implementing molecular and genomic tests in practice. Personalized medicines are used in the treatment of diseases such as breast cancer and cardiovascular diseases. The personalized anticancer medicines exhibit fewer and less severe side effects than other types of treatment as they are designed for more specific action. Further, with the ongoing progress in research and clinical studies, personalized medicines are likely to reach even greater potential to improve the quality of patient care. Thus, the growing focus on personalized medicines is boosting the anatomic pathology market growth. Also, the rising number of clinical trials for the anticancer drugs is likely to support for the growth of the anatomic pathology market in the coming years.

The impact of the COVID-19 pandemic on cancer patients is high in terms of anxiety, fear, and psychological distress. Moreover, the supply of diagnostics kits and assays is delayed because of the increase in quarantine time and the shutdown of all business operations. The COVID-19 pandemic has become the largest challenge to this region. For instance, due to the high uncertainty of the spread of COVID-19, the impact on Africa is expected to be severe, given the continent’s exposure to China. The COVID-19 outbreak has hampered the already weak healthcare systems in Africa. Due to the necessity of laboratory capacity and medical supplies, detecting the virus in African countries is a challenge. To overcome this challenge, the WHO helped 36 African countries with virus testing kits. Also, they are training and providing personal shielding equipment to health workers in Africa. however, it has a negative impact on the Middle East and Africa anatomic pathology market in coming years.

 

Key Market Segments

Based on product and service, the Middle East and Africa anatomic pathology market is segmented into instruments, consumables, and services. The services segment is likely to hold the largest share of the market in 2021, however, instruments segment is anticipated to register the highest CAGR of the market during the forecast period.

Based on application, the Middle East and Africa anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment is likely to hold the largest share of the market in 2021, however, drug discovery and development segment is anticipated to register the highest CAGR of the market during the forecast period.

Based on end user, the Middle East and Africa anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. Others includes pharmaceutical and biotechnology companies, and contract research organization (CROs). The hospitals segment is likely to hold the largest share of the market in 2021, however, diagnostic laboratories segment is anticipated to register the highest CAGR of the market during the forecast period.

 

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Middle East and Africa anatomic pathology market are the Centers for Disease Control and Prevention (CDC), Gulf Cooperation Council (GCC) and World Health Organization (WHO).

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of Middle East and Africa anatomic pathology market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the Middle East and Africa anatomic pathology market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa anatomic pathology market.

MIDDLE EAST AND AFRICA ANATOMIC PATHOLOGY MARKET SEGMENTATION

By Products and Services

  • Services
  • Consumables
  • Instruments

By Application

  • Disease Diagnosis
  • Drug Discovery and Development
  • Others

By End User

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

By Country

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Company Profiles

  • F. HOFFMANN-LA ROCHE LTD.
  • Danaher
  • Hologic, Inc.
  • Agilent Technologies, Inc.
  • BioGenex
  • Diapath S.p.A.
  • Bio SB
  • MERCK KGaA
  • BD
  • PHC Holdings Corporation

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East and Africa Anatomic Pathology Market – By Product and Services

1.3.2        Middle East and Africa Anatomic Pathology Market – By Application

1.3.3        Middle East and Africa Anatomic Pathology Market – By End User

1.3.4        Middle East and Africa Anatomic Pathology Market – By Country

2.           Anatomic Pathology Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Anatomic Pathology Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East and Africa (MEA) – PEST Analysis

4.3         Expert Opinions

5.           Anatomic Pathology Market — Key Market Dynamics

5.1         Key Market Drivers

5.1.1              Increase in Prevalence of Cancer and Other Diseases

5.1.2              Growing Focus on Personalized Medicines

5.2         Key Market Restraints

5.2.1              Lack of Skilled Professionals

5.2.2              Stringency of Government Regulations

5.3         Key Market Opportunities

5.3.1              Rise in Number of Clinical Trials for Anticancer Drugs

5.4         Future Trends

5.4.1              Development of New Technologies and Launch of Products

5.5         Impact Analysis

6.           Anatomic Pathology Market –Middle East and Africa Analysis

6.1         Middle East and Africa Anatomic Pathology Market Revenue Forecast and Analysis

7.           Anatomic Pathology Market Analysis – By Product and Service

7.1         Overview

7.2         Anatomic Pathology Market, by Product and Service (2020 and 2028)

7.3         Instruments

7.3.1        Overview

7.3.2        Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Consumables

7.4.1        Overview

7.4.2        Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Services

7.5.1        Overview

7.5.2        Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

8.           Anatomic Pathology Market Analysis – By Application

8.1         Overview

8.2         Anatomic Pathology Market, by Application (2020 and 2028)

8.3         Disease Diagnosis

8.3.1        Overview

8.3.2        Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Drug Discovery and Development

8.4.1        Overview

8.4.2        Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

9.           Anatomic Pathology Market Analysis – By End User

9.1         Overview

9.2         Anatomic Pathology Market, by End User (2020 and 2028)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Research Laboratories

9.4.1        Overview

9.4.2        Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Laboratories

9.5.1        Overview

9.5.2        Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

10.        Anatomic Pathology Market – Middle East and Africa Analysis

10.1      Middle East and Africa: Anatomic Pathology Market

10.1.1     Overview

10.1.2     Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2028 (US$ Million)

10.1.3     Middle East and Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

1.1.1.1    Middle East and Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.4     Middle East and Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.5     Middle East and Africa: Anatomic Pathology Market, by Country, 2021 & 2028 (%)

10.1.5.1       Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2028 (USD Million)

10.1.5.1.1       Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.6     Saudi Arabia Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

10.1.7     Saudi Arabia Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.8     Saudi Arabia Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.8.1       UAE: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.1.1       UAE: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.9     UAE Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

1.1.1.2    UAE Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.10  UAE Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.10.1    South Africa: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.10.1.1    South Africa: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.11  South Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

10.1.12  South Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.13  South Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.13.1    Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2028 (USD Million)

10.1.13.1.1    Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2028 (USD Million)

10.1.14  Rest of Middle East and Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

1.1.1.3    Rest of Middle East and Africa Anatomic Pathology Market, by Services – Revenue and Forecast to 2028 (USD Million)

1.1.1.4    Rest of Middle East and Africa Anatomic Pathology Market, by Instruments – Revenue and Forecast to 2028 (USD Million)

10.1.15  Rest of Middle East and Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.16  Rest of Middle East and Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact of COVID-19 Pandemic on Middle East and Africa Anatomic Pathology Market

11.1      Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12.        Anatomic Pathology Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      F.HOFFMANN-LA ROCHE LTD.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Danaher

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Hologic, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      BioGenex

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Diapath S.p.A.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bio SB

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      MERCK KGaA

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      BD

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      PHC Holdings Corporation

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Middle East and Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 2.             Middle East and Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 3.             Middle East and Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 4.             Saudi Arabia Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6.             Saudi Arabia Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7.             UAE Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 8.             UAE Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 9.             UAE Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          South Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 11.          South Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          South Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of Middle East and Africa Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of Middle East and Africa Anatomic Pathology Market, by Services – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of Middle East and Africa Anatomic Pathology Market, by Instruments – Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of Middle East and Africa Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of Middle East and Africa Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 18.          Organic Developments Done by Companies

Table 19.          Inorganic Developments Done by Companies

Table 20.          Glossary of Terms, Anatomic Pathology Market

 


LIST OF FIGURES

Figure 1.           Anatomic Pathology Market Segmentation

Figure 2.           Anatomic Pathology Market Segmentation, By Country

Figure 3.           Anatomic Pathology Market Overview

Figure 4.           Services Segment Held Largest Share of Anatomic Pathology Market

Figure 5.           Middle East and Africa Anatomic Pathology Market – Leading Country Markets (US$ Million)

Figure 6.           Middle East and Africa (MEA) PEST Analysis

Figure 7.           Middle East and Africa Anatomic Pathology Market Impact Analysis of Drivers and Restraints

Figure 8.           Middle East and Africa Anatomic Pathology Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Anatomic Pathology Market Revenue Share, by Product and Service (2020 and 2028)

Figure 10.        Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Anatomic Pathology Market Revenue Share, by Application (2020 and 2028)

Figure 14.        Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Anatomic Pathology Market Revenue Share, by End User (2020 and 2028)

Figure 18.        Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Middle East and Africa: Anatomic Pathology Market, by Key Country – Revenue (2021) (USD Million)

Figure 23.        Middle East and Africa Anatomic Pathology Market Revenue and Forecast to 2028 (USD Million)

Figure 24.        Middle East and Africa: Anatomic Pathology Market, by Country, 2021 & 2028 (%)

Figure 25.        Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        UAE: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        South Africa: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2028 (USD Million)

Figure 29.        Impact Of COVID-19 Pandemic in Middle East and Africa Countries Market

  1. F. HOFFMANN-LA ROCHE LTD.
  2. Danaher
  3. Hologic, Inc.
  4. Agilent Technologies, Inc.
  5. BioGenex
  6. Diapath S.p.A.
  7. Bio SB
  8. MERCK KGaA
  9. BD
  10. PHC Holdings Corporation
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa anatomic pathology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa anatomic pathology market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Related Tags Middle East and Africa Anatomic Pathology Market Middle East and Africa Anatomic Pathology Market Research Middle East and Africa Anatomic Pathology Market Insight Middle East and Africa Anatomic Pathology Market Trends Middle East and Africa Anatomic Pathology Market Forecast Middle East and Africa Anatomic Pathology Market Share Middle East and Africa Anatomic Pathology Market 2028 Middle East and Africa Anatomic Pathology Market Growth Middle East and Africa Anatomic Pathology Industry Sector Middle East and Africa Anatomic Pathology PDF Report Middle East and Africa Anatomic Pathology Analysis Middle East and Africa Anatomic Pathology Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000